Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Cutaneous Neurofibroma of the Ear Pinna: A Report of Two Case

Rajat Bhende, Muthalib Abdul, Rajesh Kshirsagar, Swapna Patankar, Priyadarshini Banerjee, Ruturaj Deshpande

Aim & Objective: To present the current considerations, natural history and treatment modalities of cutaneous neurofibromas (cNF)

Methods: Cutaneous Neurofibroma experts from various research and clinical backgrounds reviewed the terms currently in use for cNF as well as the clinical, histologic, and radiographic features of these tumors using available data.

Aim & Objective: To present the current considerations, natural history and treatment modalities of cutaneous neurofibromas (cNF)

Methods: Cutaneous Neurofibroma experts from various research and clinical backgrounds reviewed the terms currently in use for cNF as well as the clinical, histologic, and radiographic features of these tumors using available data.

Results: Neurofibromas develop within nerves, soft tissue, and skin. The primary distinction between cNF and other neurofibromas is that cNF are limited to the skin whereas other neurofibromas may involve the skin, but are not limited to the skin. There are important cellular, molecular, histologic, and clinical features of cNF. Each of these factors is discussed in consideration of a clinicopathologic framework for cNF.

Conclusion: The development of various treatment options for neurofibroma requires formulation of diagnostic criteria that encompass the clinical and histologic features of these tumors. However, the rear several areas of overlap between cNF and other neurofibromas that make distinctions between cutaneous and other neurofibromas more difficult, requiring careful deliberation with input across the multiple disciplines that encounter these tumors and ultimately, prospective validation. The ultimate goal of this work is to facilitate accurate diagnosis and meaningful therapeutics for cNF.